Medpace (MEDP) Competitors $321.50 -4.53 (-1.39%) Closing price 07/3/2025 02:02 PM EasternExtended Trading$321.18 -0.32 (-0.10%) As of 07/3/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MEDP vs. ICLR, EHC, ELV, HIMS, IQV, RDDT, GIB, CPAY, TOST, and AERShould you be buying Medpace stock or one of its competitors? The main competitors of Medpace include Icon (ICLR), Encompass Health (EHC), Elevance Health (ELV), Hims & Hers Health (HIMS), IQVIA (IQV), Reddit (RDDT), CGI Group (GIB), Corpay (CPAY), Toast (TOST), and Aercap (AER). Medpace vs. Its Competitors Icon Encompass Health Elevance Health Hims & Hers Health IQVIA Reddit CGI Group Corpay Toast Aercap Icon (NASDAQ:ICLR) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk. Do analysts rate ICLR or MEDP? Icon presently has a consensus price target of $213.08, suggesting a potential upside of 42.00%. Medpace has a consensus price target of $344.82, suggesting a potential upside of 7.25%. Given Icon's stronger consensus rating and higher possible upside, research analysts clearly believe Icon is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Icon 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.60Medpace 0 Sell rating(s) 11 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.21 Which has better valuation & earnings, ICLR or MEDP? Icon has higher revenue and earnings than Medpace. Icon is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIcon$8.28B1.46$791.47M$9.1816.35Medpace$2.11B4.38$404.39M$13.1024.54 Does the media prefer ICLR or MEDP? In the previous week, Medpace had 2 more articles in the media than Icon. MarketBeat recorded 6 mentions for Medpace and 4 mentions for Icon. Medpace's average media sentiment score of 0.70 beat Icon's score of 0.27 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Medpace 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is ICLR or MEDP more profitable? Medpace has a net margin of 19.31% compared to Icon's net margin of 9.25%. Medpace's return on equity of 54.36% beat Icon's return on equity.Company Net Margins Return on Equity Return on Assets Icon9.25% 11.46% 6.49% Medpace 19.31%54.36%20.81% Which has more volatility & risk, ICLR or MEDP? Icon has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Do institutionals and insiders hold more shares of ICLR or MEDP? 95.6% of Icon shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 44.0% of Icon shares are owned by insiders. Comparatively, 20.3% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryMedpace beats Icon on 9 of the 17 factors compared between the two stocks. Get Medpace News Delivered to You Automatically Sign up to receive the latest news and ratings for MEDP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MEDP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEDP vs. The Competition Export to ExcelMetricMedpaceMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.24B$7.31B$5.54B$9.05BDividend YieldN/A2.78%5.24%4.02%P/E Ratio24.5427.9427.4320.23Price / Sales4.3832.39422.11118.64Price / Cash23.0422.0136.8958.07Price / Book12.106.698.045.67Net Income$404.39M$233.06M$3.18B$249.13M7 Day Performance3.48%3.33%2.89%3.28%1 Month Performance9.51%3.72%3.70%5.56%1 Year Performance-20.10%37.40%36.15%21.12% Medpace Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDPMedpace4.4612 of 5 stars$321.50-1.4%$344.82+7.3%-20.2%$9.24B$2.11B24.545,900ICLRIcon4.3791 of 5 stars$145.45+0.6%$213.08+46.5%-52.8%$11.75B$8.28B15.8441,900EHCEncompass Health4.8458 of 5 stars$122.60+0.3%$127.00+3.6%+38.4%$12.36B$5.37B25.3340,000Positive NewsEx-DividendELVElevance Health4.9734 of 5 stars$389.42+2.1%$498.87+28.1%-34.2%$87.98B$183.12B15.19102,300HIMSHims & Hers Health2.2033 of 5 stars$49.94+1.1%$39.58-20.7%+133.8%$11.18B$1.48B72.381,637Trending NewsInsider TradeIQVIQVIA4.9141 of 5 stars$157.69+0.1%$226.32+43.5%-20.6%$27.28B$15.41B21.4886,000RDDTReddit2.3051 of 5 stars$150.74+5.4%$139.57-7.4%+113.7%$27.81B$1.30B255.502,233Trending NewsAnalyst ForecastInsider TradeGIBCGI Group3.9051 of 5 stars$104.93+1.5%$156.75+49.4%+3.9%$23.55B$10.79B19.1190,000Positive NewsCPAYCorpay3.9481 of 5 stars$332.07+1.5%$401.86+21.0%+26.8%$23.41B$3.97B23.2910,500Positive NewsTOSTToast2.7778 of 5 stars$44.33+1.0%$41.21-7.0%+72.2%$22.08B$4.96B192.744,500Positive NewsAnalyst DowngradeAERAercap2.5684 of 5 stars$116.96-0.2%$119.25+2.0%+23.4%$21.85B$8.06B10.38740Gap Up Related Companies and Tools Related Companies Icon Alternatives Encompass Health Alternatives Elevance Health Alternatives Hims & Hers Health Alternatives IQVIA Alternatives Reddit Alternatives CGI Group Alternatives Corpay Alternatives Toast Alternatives Aercap Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MEDP) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDP Stock Alerts